Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Could Regeneron's Antibody Therapy Be as Important as Vaccines in Fighting COVID?

TheMotleyFool

0 0

Could Regeneron's Antibody Therapy Be as Important as Vaccines in Fighting COVID?

Regeneron Pharmaceuticals (NASDAQ: REGN) recently announced overwhelmingly positive results from a late-stage study of its antibody cocktail therapy in treating individuals infected with COVID-19. In this Motley Fool Live video recorded on March 24, 2021, Motley Fool contributors Keith Speights and Brian Orelli discuss whether or not Regeneron's therapy could be as important as vaccines in the fight against COVID-19.

Source Fool.com

Like: 0

REGN

Share